Phaseline

Targets › IL21

IL21 (Interleukin-21): drug programs, companies and trials

4 programs from 4 companies in 8 trials: 5 Phase 1, 3 Phase 2; Oncology; next expected readout Jun 2027.

Cytokine with immunoregulatory activity. May promote the transition between innate and adaptive immunity. (UniProt, Q9HBE4)

Open in Phaseline: the race on IL21, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Hangzhou ConverdhV01
Recombinant vaccinia virus with deletions of viral thymidine kinase (TK) and viral growth
IL21Phase 2Advanced Pancreatic Cancer; Advanced Solid TumorsJun 2027
Daihong LiuPD-1Ab21-BCMA CAR-T
BCMA-targeting CAR-T cells secreting PD-1 antibody and interleukin-21 fusion protein
BCMA, PDCD1, IL21Phase 2Multiple MyelomaJul 2027
Federal Research Institute of Pediatric Hematology, Oncology and ImmunologymbIL21 ex vivo-expanded donor-derived NK cells
IL-21-engineered natural killer cells for leukemia relapse prophylaxis
IL21Phase 2Acute Myeloid LeukemiaOct 2027
M.D. Anderson Cancer CenterCytokine-treated Veto Cells
CAR-T/CAR-NK cell therapy targeting IL-13 receptor alpha-1 and EGFvIII on glioblastoma cel
IL13RA1, EGFR, IL21, TGFBR2, NR3C1, TROP2Phase 1Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Phase 1; Colorectal CancerDec 2027

Conditions

Acute Myeloid Leukemia (2) Advanced Pancreatic Cancer (1) Advanced Solid Tumors (1) Multiple Myeloma (1) Acute Lymphoblastic Leukemia (1) Phase 1 (1) Colorectal Cancer (1)

Modalities

other (3), mixed (1)

Companies

Hangzhou Converd (1) Federal Research Institute of Pediatric Hematology, Oncology and Immunology (1) Daihong Liu (1) M.D. Anderson Cancer Center (1)

Related targets

BCMA (1) PDCD1 (1) IL13RA1 (1) EGFR (1) TGFBR2 (1) NR3C1 (1) TROP2 (1)

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.